Hepatocellular carcinoma (HCC) is the only factor affecting the excellent survival of Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis under long-term entecavir (ETV) or tenofovir (TDF) therapy

George V. Papatheodoridis; George N. Dalekos; Cihan Yurdaydin; Florian van Boemmel; Maria Buti; Vana Sypsa; John Goulis; Jose L. Calleja; Heng Chi; Spilios Manolakopoulos; Alessandro Loglio; Nikolaos Gatselis; Onur Keskin; Maria Lehretz; Savvoula Savvidou; Juan de la Revilla; Bettina E. Hansen; Jiannis Vlachogiannakos; Kostas Galanis; Ramazan Idilman; Massimo Colombo; Rafael Esteban; Harry L. Janssen; Thomas Berg; Pietro Lampertico

Hepatocellular carcinoma (HCC) is the only factor affecting the excellent survival of Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis under long-term entecavir (ETV) or tenofovir (TDF) therapy

George V. Papatheodoridis
, George N. Dalekos
, Cihan Yurdaydin
, Florian van Boemmel
, Maria Buti
, Vana Sypsa
, John Goulis
, Jose L. Calleja
, Heng Chi
, Spilios Manolakopoulos
, Alessandro Loglio
, Nikolaos Gatselis
, Onur Keskin
, Maria Lehretz
, Savvoula Savvidou
, Juan de la Revilla
, Bettina E. Hansen
, Jiannis Vlachogiannakos
, Kostas Galanis
, Ramazan Idilman

Massimo Colombo, Rafael Esteban, Harry L. Janssen, Thomas Berg, Pietro Lampertico

Division of Internal Medicine (Medicine)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	35A-36A
Number of pages	2
Journal	Hepatology
Volume	64
Publication status	Published - Oct 2016
Event	67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) - Boston, Morocco Duration: 11 Nov 2016 → 15 Nov 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Papatheodoridis, G. V., Dalekos, G. N., Yurdaydin, C., van Boemmel, F., Buti, M., Sypsa, V., Goulis, J., Calleja, J. L., Chi, H., Manolakopoulos, S., Loglio, A., Gatselis, N., Keskin, O., Lehretz, M., Savvidou, S., de la Revilla, J., Hansen, B. E., Vlachogiannakos, J., Galanis, K., ... Lampertico, P. (2016). Hepatocellular carcinoma (HCC) is the only factor affecting the excellent survival of Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis under long-term entecavir (ETV) or tenofovir (TDF) therapy. Hepatology, 64, 35A-36A.

@article{f52336e9ef78483fb9152eb89a2e94e9,

title = "Hepatocellular carcinoma (HCC) is the only factor affecting the excellent survival of Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis under long-term entecavir (ETV) or tenofovir (TDF) therapy",

author = "Papatheodoridis, \{George V.\} and Dalekos, \{George N.\} and Cihan Yurdaydin and \{van Boemmel\}, Florian and Maria Buti and Vana Sypsa and John Goulis and Calleja, \{Jose L.\} and Heng Chi and Spilios Manolakopoulos and Alessandro Loglio and Nikolaos Gatselis and Onur Keskin and Maria Lehretz and Savvoula Savvidou and \{de la Revilla\}, Juan and Hansen, \{Bettina E.\} and Jiannis Vlachogiannakos and Kostas Galanis and Ramazan Idilman and Massimo Colombo and Rafael Esteban and Janssen, \{Harry L.\} and Thomas Berg and Pietro Lampertico",

year = "2016",

month = oct,

language = "English",

volume = "64",

pages = "35A--36A",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Lippincott Williams and Wilkins",

note = "67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) ; Conference date: 11-11-2016 Through 15-11-2016",

}

Papatheodoridis, GV, Dalekos, GN, Yurdaydin, C, van Boemmel, F, Buti, M, Sypsa, V, Goulis, J, Calleja, JL, Chi, H, Manolakopoulos, S, Loglio, A, Gatselis, N, Keskin, O, Lehretz, M, Savvidou, S, de la Revilla, J, Hansen, BE, Vlachogiannakos, J, Galanis, K, Idilman, R, Colombo, M, Esteban, R, Janssen, HL, Berg, T & Lampertico, P 2016, 'Hepatocellular carcinoma (HCC) is the only factor affecting the excellent survival of Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis under long-term entecavir (ETV) or tenofovir (TDF) therapy', Hepatology, vol. 64, pp. 35A-36A.

Hepatocellular carcinoma (HCC) is the only factor affecting the excellent survival of Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis under long-term entecavir (ETV) or tenofovir (TDF) therapy. / Papatheodoridis, George V.; Dalekos, George N.; Yurdaydin, Cihan et al.
In: Hepatology, Vol. 64, 10.2016, p. 35A-36A.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Hepatocellular carcinoma (HCC) is the only factor affecting the excellent survival of Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis under long-term entecavir (ETV) or tenofovir (TDF) therapy

AU - Papatheodoridis, George V.

AU - Dalekos, George N.

AU - Yurdaydin, Cihan

AU - van Boemmel, Florian

AU - Buti, Maria

AU - Sypsa, Vana

AU - Goulis, John

AU - Calleja, Jose L.

AU - Chi, Heng

AU - Manolakopoulos, Spilios

AU - Loglio, Alessandro

AU - Gatselis, Nikolaos

AU - Keskin, Onur

AU - Lehretz, Maria

AU - Savvidou, Savvoula

AU - de la Revilla, Juan

AU - Hansen, Bettina E.

AU - Vlachogiannakos, Jiannis

AU - Galanis, Kostas

AU - Idilman, Ramazan

AU - Colombo, Massimo

AU - Esteban, Rafael

AU - Janssen, Harry L.

AU - Berg, Thomas

AU - Lampertico, Pietro

PY - 2016/10

Y1 - 2016/10

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000385493800069&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 0270-9139

VL - 64

SP - 35A-36A

JO - Hepatology

JF - Hepatology

T2 - 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Y2 - 11 November 2016 through 15 November 2016

ER -

Hepatocellular carcinoma (HCC) is the only factor affecting the excellent survival of Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis under long-term entecavir (ETV) or tenofovir (TDF) therapy

UN SDGs

Other files and links

Cite this